Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners

Assessment of Dentist Pharmacist Communication About Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

Study Overview

• Status: Completed
• Conditions: Bruxism; Temporomandibular Joint Disorders
• Intervention / Treatment: Other: a self structured questionnaire

Detailed Description

Skeletal muscle relaxants (SMR) are a diverse group of medications that are not chemically related like other drug classes and work through a variety of mechanisms. The term "muscle relaxant" is used to refer to two major therapeutic groups: neuromuscular blockers and spasmolytic. Some of them are working mainly through the central nervous system; they have many adverse effects such as sedation and dizziness that may limit their use.

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

• Study Type: Observational
• Enrollment (Actual): 170

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • Future University in Egypt

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 60 years (ADULT)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

dental practitioners in Egypt (professionals both academic and nonacademic).

Description

Inclusion Criteria:

• academic dental practitioners in Egypt
• nonacademic dental practitioners in Egypt

Exclusion Criteria:

• Age less than 20 or more than 60
• Non-dental

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Egyptian dental practitioners; 170 dental practitioners in Egypt (professionals both academic and nonacademic).	Other: a self structured questionnaire; A self structured questionnaire to assess knowledge of skeletal muscle use in dental practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Dental practitioner's knowledge about muscle relaxants indications	Extent of dental practitioner's knowledge about muscle relaxants indications in practice	1 month
importance of direct communication between dental practitioners and pharmacists in order to detect the communication barriers and how to overcome those barriers.	To assess and improve the communication between pharmacist- dentist regarding Skeletal muscle relaxant	1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Dental practitioner's knowledge about muscle relaxants doses	Extent of dental practitioner's knowledge about muscle relaxants different doses in practice	1 month
Dental practitioner's knowledge about muscle relaxants side effects	Extent of dental practitioner's knowledge about muscle relaxants possible side effects	1 month

Collaborators and Investigators

• Sponsor: Future University in Egypt
• Collaborators: Cairo University; Ain Shams University; British University In Egypt

Study record dates

Study Major Dates

• Study Start (ACTUAL): February 10, 2021
• Primary Completion (ACTUAL): March 10, 2021
• Study Completion (ACTUAL): March 15, 2021

Study Registration Dates

• First Submitted: February 5, 2021
• First Submitted That Met QC Criteria: February 5, 2021
• First Posted (ACTUAL): February 10, 2021

Study Record Updates

• Last Update Posted (ACTUAL): May 27, 2022
• Last Update Submitted That Met QC Criteria: May 24, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Neurologic Manifestations; Musculoskeletal Diseases; Muscular Diseases; Stomatognathic Diseases; Neuromuscular Manifestations; Tooth Diseases; Jaw Diseases; Craniomandibular Disorders; Mandibular Diseases; Myofascial Pain Syndromes; Joint Diseases; Bruxism; Temporomandibular Joint Disorders; Temporomandibular Joint Dysfunction Syndrome; Muscle Hypotonia
• Other Study ID Numbers: FUE.REC 1/1-2021

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No